Aidoc Secures $150M to Scale AI Imaging Tools

Why It Matters

The infusion accelerates Aidoc’s push to embed AI across the entire radiology workflow, positioning it to capture a growing share of the multi‑billion‑dollar medical imaging market.

Key Takeaways

• Aidoc's Series E brings total funding above $500 million
• Funds target global expansion and new CARE foundation model
• AI triage tool cleared for 14 combined indications
• Draft‑report automation aims for end‑to‑end workflow by 2026
• Investors include Goldman Sachs, General Catalyst, SoftBank, NVIDIA

Pulse Analysis

The medical imaging sector is undergoing a rapid AI transformation, with venture capital flowing toward firms that can automate diagnosis and streamline radiology workflows. Aidoc’s latest $150 million raise reflects investor confidence that AI can move beyond point‑of‑care alerts to full‑scale decision support. By joining a cohort that includes DeepMind Health and Zebra Medical Vision, Aidoc is leveraging its extensive FDA clearances to differentiate itself in a crowded market where regulatory approval is a key moat.

Aidoc’s CARE foundation model represents a shift toward foundation‑model‑based reasoning, enabling the company to train a single engine on diverse imaging modalities and then fine‑tune for specific clinical tasks. The new draft‑report automation feature promises to cut radiologists’ reporting time by generating preliminary narratives directly from CT and X‑ray scans. Combined with the recent clearance of a 14‑indication triage suite, these capabilities could reduce diagnostic latency and lower error rates, aligning with the CEO’s vision of AI‑assisted decision‑making for every complex diagnosis by 2030.

For health systems, the funding translates into faster access to scalable AI tools that can be deployed across multiple sites. The involvement of heavyweight investors such as Goldman Sachs and NVIDIA signals a belief that AI imaging will become a core revenue driver for hospitals seeking efficiency gains and improved patient outcomes. As reimbursement models evolve to reward value‑based care, platforms that integrate AI throughout the imaging pipeline are likely to see accelerated adoption, making Aidoc a strategic partner for providers aiming to stay ahead of the technology curve.